France vs Iceland: Measles-containing-vaccine second-dose (MCV2) immunization coverage
France
93.0%
in 2025
Iceland
93.0%
in 2025
France rank
49th
Iceland rank
49th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- France
- Iceland
How they compare
France currently reports 93.0% against 93.0% in Iceland, a difference of 0.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Iceland ahead.
France ranks 49th and Iceland ranks 49th of 194 countries.
Across the 3 decades both report, France averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | France | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 64.6% | 64.6% | Iceland |
| 2010s | 76.0% | 93.9% | 17.9% | Iceland |
| 2020s | 92.3% | 90.3% | 2.0% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, France or Iceland?
- France, at 93.0% against 93.0% in Iceland as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between France and Iceland?
- 0.0%, with France ahead.
- How many years of comparable data are there for France and Iceland?
- 26 years are reported by both, from 2000 to 2025.
- How do France and Iceland rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- France ranks 49th and Iceland ranks 49th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.